| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.3B | $2.2B | $2.1B | $1.8B | $1.6B | $0.4B | $1.4B | $0.3B |
| Cost of Revenue | $1.1B | $1.0B | $1.0B | $0.9B | $0.8B | $0.2B | $0.2B | $0.2B |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | $0.3B | $0.3B | $0.3B | $0.3B | $0.3B | $0.2B | $0.2B | $0.2B |
| SG&A Expense | $0.5B | $0.5B | $0.5B | $0.4B | $0.3B | $0.1B | $0.1B | $0.1B |
| Operating Income | $0.7B | $0.7B | $0.6B | $0.5B | $0.5B | $0.1B | $0.1B | $0.1B |
| Net Income | $0.6B | $0.5B | $0.5B | $0.4B | $0.4B | $0.1B | $0.1B | $0.1B |
| EPS (Basic) | $15.74 | $14.11 | $12.26 | $10.48 | $10.56 | $9.83 | $9.25 | $6.90 |
| EPS (Diluted) | $15.55 | $13.91 | $12.04 | $10.25 | $10.36 | $2.29 | $2.34 | $1.77 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $4.3B | $4.1B | $4.0B | $4.0B | $2.2B | $2.1B | $1.6B | $1.4B |
| Current Assets | $0.7B | $0.8B | $0.8B | $0.9B | $0.9B | $0.8B | $0.6B | $0.4B |
| Cash & Equivalents | $0.3B | $0.4B | $0.4B | $0.5B | $0.7B | $0.6B | $0.4B | $0.2B |
| Total Liabilities | $2.1B | $2.1B | $2.3B | $2.7B | $1.2B | $1.2B | $0.9B | $0.9B |
| Current Liabilities | $0.5B | $0.7B | $0.5B | $0.4B | $0.3B | $0.3B | $0.2B | $0.2B |
| Stockholders' Equity | $2.2B | $1.9B | $1.6B | $1.3B | $1.0B | $0.9B | $0.7B | $0.5B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.7B | $0.7B | $0.6B | $0.5B | $0.6B | $0.5B | $0.4B | $0.4B |
| Investing Cash Flow | $-0.4B | $-0.1B | $-0.1B | $-2.0B | $-0.1B | $-0.1B | $-0.1B | $-0.0B |
| Capital Expenditures | — | — | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.0B |
| Financing Cash Flow | $-0.4B | $-0.6B | $-0.6B | $1.3B | $-0.3B | $-0.2B | $-0.2B | $-0.3B |